Switch to:
More From Other Websites
ETFs with exposure to Biocept, Inc. : January 19, 2017 Jan 19 2017
Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture... Jan 19 2017
Latest Reports on Biocept and Apricus Biosciences as President Trump's Comments Put Pressure on Drug... Jan 13 2017
Tuesday’s Top Biopharma Movers Jan 10 2017
Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas Jan 10 2017
Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to... Dec 27 2016
Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to... Dec 27 2016
Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the... Dec 08 2016
Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biopsy Test at the... Dec 07 2016
Teladoc November Visits Set Record: Why is Stock Suffering? Dec 07 2016
ETFs with exposure to Biocept, Inc. : December 5, 2016 Dec 05 2016
BIOCEPT INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule... Dec 02 2016
Biocept to Present at the LD Micro Main Event Nov 21 2016
BIOCEPT INC Financials Nov 18 2016
ETFs with exposure to Biocept, Inc. : November 14, 2016 Nov 14 2016
BIOCEPT INC Files SEC form 10-Q, Quarterly Report Nov 10 2016
Biocept, Inc. :BIOC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016 Nov 10 2016
Biocept Reports 2016 Third Quarter Financial Results Nov 09 2016
BIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 09 2016
Biocept Reports 2016 Third Quarter Financial Results Nov 09 2016
Q3 2016 Biocept Inc Earnings Release - After Market Close Nov 09 2016
BIOCEPT INC Files SEC form 8-K, Termination of a Material Definitive Agreement Nov 04 2016
Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9,... Oct 31 2016
Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9,... Oct 31 2016
BIOCEPT INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule... Oct 28 2016
Biocept Appoints David Moskowitz Vice President, Strategy & Corporate Communications Oct 27 2016
Biocept Announces Closing of $10 Million Public Offering of Common Stock and Warrants Oct 19 2016
Biocept Announces Pricing of $10 Million Public Offering of Common Stock and Warrants Oct 14 2016
/C O R R E C T I O N -- Biocept, Inc./ Oct 05 2016
Biocept to Collaborate with Renowned Clinical Investigator Dr. Shilpa Gupta to Study the Utility of... Sep 09 2016
Biocept Expands Chinese Patent Protection Covering Key Technologies for Circulating Tumor Cell... Sep 01 2016
Biocept Announces Agreement with Teneovita Medical to Market and Distribute its Liquid Biopsy... Aug 30 2016
Biocept to Present at Next Generation Dx Summit Aug 18 2016
Biocept Expands Distribution of Liquid Biopsy Tests to the Philippines Aug 11 2016
Biocept Reports 2016 Second Quarter Financial Results Aug 02 2016
Biocept Appoints Timothy C. Kennedy as Chief Financial Officer and Senior Vice President of... Jul 27 2016
Biocept to Release Second Quarter Financial Results on August 2, 2016 and Host Investor Conference... Jul 25 2016
Biocept Granted Japanese Patent Covering Microchannel and Antibody Capture Jul 05 2016
Biocept Comments on Reimbursement Provisions in CMS' Final PAMA Rule Jun 29 2016
Biocept Launches Liquid Biopsy Immuno-Oncology PD-L1 Test May 31 2016
High Sensitivity of Biocept's Target Selector Blood-Based Liquid Biopsy Tests Featured in Two... May 25 2016
Biocept Announces Master Services Agreement with Pharma Company to Develop Liquid Biopsy Tests May 23 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK